Quick Answer
MEDIFAST INC reported Revenue (ASC 606) of $385.79 million for fiscal year 2025.
MEDIFAST INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $385.79M | -36.0% |
| 2024 | $602.46M | -43.8% |
| 2023 | $1.07B | -32.9% |
| 2022 | $1.60B | +4.8% |
| 2021 | $1.53B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $89.41M | -36.2% | -15.3% |
| June 30, 2025 | $105.56M | -37.4% | -8.8% |
| March 31, 2025 | $115.73M | -33.8% | -17.4% |
| September 30, 2024 | $140.16M | -40.6% | -16.8% |
| June 30, 2024 | $168.56M | -43.1% | -3.5% |
| March 31, 2024 | $174.74M | -49.9% | -25.9% |
| September 30, 2023 | $235.87M | -39.6% | -20.4% |
| June 30, 2023 | $296.19M | -34.7% | -15.1% |
- MEDIFAST INC showed a decrease of -36.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2021–2025 period, MEDIFAST INC’s revenue (asc 606) has declined by 74.7% (from $1.53 billion to $385.79 million).
- The most recent figure is from MEDIFAST INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: